Results

Total Results: 1,583 records

Showing results for "liver".
Users also searched for: hepatitis c

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
    April 01, 2014 - comorbidities in this population, since many types of cancer and less common comorbidities such as liver
  2. Menopause Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
    March 01, 2015 - Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver- unspecific Naranjo
  3. digital.ahrq.gov/sites/default/files/docs/citation/r01hs015274-carayon-final-report-2009.pdf
    January 01, 2009 - All CV surgery patients and acute MI/post­ catheterization; kidney, pancreas or liver transplants
  4. integrationacademy.ahrq.gov/products/topic-briefs/polysubstance-use
    February 01, 2025 - Alcohol Use Disorders Identification Test - Alcoholic Liver Disease. Washington DC:U.S.
  5. digital.ahrq.gov/sites/default/files/docs/citation/r01hs020909-dixon-final-report-2017.pdf
    January 01, 2017 - only included test results data for a case of hepatitis B but also corollary results on the patient's liver
  6. digital.ahrq.gov/sites/default/files/docs/citation/r21hs023952-chrischilles-final-report-2018.pdf
    January 01, 2018 - significant hepatic disease including cirrhosis, chronic hepatitis B or C, or have current elevated liver
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
    January 01, 2010 - insulin secretion from the pancreatic beta cells; insulin action at the level of skeletal muscle, liver
  8. psnet.ahrq.gov/web-mm/framework-assessing-reasoning-about-controversial-end-life-clinical-decisions
    November 30, 2023 - A framework for assessing reasoning about controversial end-of-life clinical decisions. Citation Text: Fedyk M, Fairman N, Romano PS, et al. A framework for assessing reasoning about controversial end-of-life clinical decisions.. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality…
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
    November 22, 2011 - treatment (including bleeding events and other adverse events such as gastrointestinal events and liver
  10. digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015339-aranaydo-final-report-2007.pdf
    January 01, 2007 - example: a patient with hepatitis has an automatic diagnosis alert on all meds metabolized by the liver
  11. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017099-weiner-final-report-2010.pdf
    January 01, 2010 - fatigue, miscellaneous disorders; and a group of more serious diagnoses, which included categories for liver
  12. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017067-kaushal-final-report-2011.pdf
    January 01, 2011 - days) Total cholesterol (6 weeks) HDL cholesterol (6 weeks) Thyroid stimulating hormone (6 weeks) Liver
  13. www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/perinatal-care-2/hypertension_4-situation-monitoring-speaker-notes.pdf
    July 01, 2023 - Smith, your labs just returned and are notable for an elevated protein/creatinine ratio and elevated liver
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/xt2Uhv4qyLUZ8o2HB_a4YQ
    July 01, 2013 - Longer-term use of ART regimens may increase the risk for cardiovascular and bone disease, as well as liver
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - systemic therapies are contraindicated or cannot be tolerated; prophylaxis of organ rejection in kidney, liver
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
    January 01, 2013 - For example, in patients with end-stage liver disease, the natural history of disease is so well known
  17. hcup-us.ahrq.gov/reports/methods/2006_1.pdf
    January 01, 2006 - infarction, peptic ulcer disease, congestive heart failure, cerebrovascular disease, hemiplegia, and severe liver
  18. effectivehealthcare.ahrq.gov/health-topics/memory
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
    February 01, 2015 - The reviews addressed four topics: drug eluting stents, lung volume reduction surgery, living donor liver … For living donor liver transplantation, there was one rapid review; for the remaining topics there were
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/_SBmXPhUQWo-dc85FJ5wHf
    February 01, 2015 - Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up,